GatesB.My message to America's top scientists. GatesNotes, February 14, 2020.
2.
StadtmauerEA, FraiettaJA, DavisMM, et al.CRISPR-engineered T cells in patients with refractory cancer. Science, 2020; 376:eaba7365. DOI: 10.1126/science.aba7365.
3.
FerdosiSR, EwaishaR, MoghadamF, et al.Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes. Nat Commun, 2019; 10:1842. DOI: 10.1038/s41467-019-09693-x.
4.
LeeJK, JeongE, LeeJ, et al.Directed evolution of CRISPR-Cas9 to increase its specificity. Nat Commun, 2018; 9:3048. DOI: 10.1038/s41467-018-05477-x.
5.
HuangCH, LeeKC, DoudnaJA. Applications of CRISPR-Cas enzymes in cancer therapeutics and detection. Trends Cancer, 2018; 4:499–512. DOI: 10.1016/j.trecan.2018.05.006.
